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INtrODUctION
CD22 is a surface immunoglobulin-like receptor expressed on mature B cells and a fraction of CD22 is constitutively associated with B-cell receptor (BCR) [1] [2] [3] [4] [5] . As an inhibitory co-receptor of the BCR, CD22 plays a critical role in setting signaling thresholds for B-cell activation. Following BCR cross-linking, CD22 Research Paper www.impactjournals.com/oncotarget inhibits a rapid increment in intracellular Ca 2+ (Ca 2+ i ) concentration ([Ca 2+ ] i ) [6] [7] . Ca 2+ i signal is required for antigen-induced proliferation and differentiation of B cells into antibody-secreting memory cells. Exaggerated Ca 2+ i signals are seen not only in B cells lacking CD22 but also in SHP-1 (tyrosine phosphatases)-deficient B cells [6] [7] [8] . Thus, CD22 and SHP-1 by attenuating Ca 2+ i signals act as negative regulators of B cell autoantibody production and preventers of autoimmunity. CD22 knockout mice have been shown to be prone to autoimmune diseases, such as lupus [9] [10] [11] . On the other hand, upregulated CD22 function has been reported in patients with immunodeficiency [12, 13] . CD22's extracellular immunoglobulin domains binds to α-2,6-linked sialic acid and its cytoplasmic domain consists of 131 amino acid containing six separately-distributed and highly-conserved tyrosine residues at amino acid 773, 783, 817, 828, 843, and 863 (Y773/Y783/Y817/Y828/Y843/Y863, designated Y1~Y6 respectively, see Figure 1A ) [1-5, 15, 16] . These tyrosine residues are rapidly phosphorylated by BCRassociated kinase Lyn and Syk upon cross-linking and each phosphorylated tyrosine serves as binding site for distinct effector proteins [17] [18] [19] . Y2/5/6 conform to an immunoreceptor tyrosine inhibitory motif (ITIM): I/VxYxxL/V. Competition assay demonstrated that phospho-peptides containing Y2/5/6 could inhibit SHP-1 binding to CD22 [16] [17] [18] 29] . Thus, Y2/5/6 is an ITIM and the binding sites for SHP-1 [19, 20] . In addition to SHP-1, ITIMs also recruit signaling molecules such as SHP-2, SHIP (an inositol 5'-phosphatase), Syk (Src family tyrosine kinase), PLC-γ2, PI3K, and SAP [16, [20] [21] [22] [23] [24] . SHP-1 is suggested to play a central role in CD22-mediated negative regulation of BCR signaling, including Ca 2+ i signals and mitogen-activated protein kinase (MAPK) cascades through dephosphorylation of various signaling molecules and regulation of PLC-γ2 activity [1, 2, 9, 18, 19, [25] [26] [27] [28] .
The remaining three tyrosines (Y1/3/4) are classified as non-ITIM. Of them, Y1, as indicated by previous work, does not associate with any effectors [20] . Y3 has been found to recruit Syk [29] . Y4 is mainly the binding site for adaptor protein Grb2 [19, 20, [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] , in addition to its association to PLC-γ2, PI3K, and adaptor Shc [20, 22, 29] . It is well known that in B cells Grb2 functions as a negative regulator of Ca 2+ i signal. However, the physiological significance of Grb2 direct binding to CD22-Y4 to execute Grb2-mediated Ca 2+ i inhibition remains unclear [32] [33] [34] [35] [36] [37] [38] .
On the other hand, the knowledge of the pathway that links CD22 to inhibition of the Ca 2+ i signal has been incomplete. Some studies have reported that CD22 may negatively regulate PLC-γ2 activity and thus reduce inositol 1,4,5-triphosphate (IP 3 ) production [8, 34] . Previous study reported that CD22 together with SHP-1 enhanced plasma membrane Ca 2+ ATPase (PMCA)-mediated Ca 2+ i efflux and thus provided a direct mechanism for its negative regulation of [Ca 2+ ] i [39] . The association between CD22 and PMCA is dependent on the cytoplasmic tyrosines phosphorylation of CD22 since mutations on all six tyrosines or cytoplasmic tail truncation prevented its binding to PMCA and lost most of the Ca 2+ i -dampening function. However, it remains to be determined which tyrosine residue(s) are involved in CD22-PMCA interaction.
In this study, we introduced serial point mutations on the six tyrosine residues in the cytoplasmic tail of CD22 and have analyzed the contributions of each tyrosine residue to Ca Previous study showed that either mutation of CD22's all six tyrosines to phenylalanines or truncation of its cytoplasmic 96 amino acid ( Figure 1A ) resulted in a complete loss of its negative regulation on Ca 2+ i and its association with PMCA [39] . In this study, we aimed to clarify which individual or a group of tyrosine residues is required for CD22's negative regulation of Ca 2+ i signal. Figure 1B shows the structure of all CD22 mutants used in this study. We utilized DT40 cells, a CD22-deficient cell line, to make stable transfectants with Empty vector (CD22-), mouse CD22-WT, and a series of mutant forms. As shown in Figure 1C , all mutants showed similar amount of expression of CD22 as compared with CD22-WT and thus were suitable for Ca amino acids and among them six tyrosines (Y1~Y6) and Grb2 binding motif were marked in capital letters. b. showed a list of CD22-WT and mutant forms (F, phenyalanine; N, asparagine; D, aspartate) constructs that were cloned into pApuro vector used in this study. c. showed the similar expression levels of all these CD22-WT and a series of mutant forms in DT40 cells.
signal and that Y1 is dispensable. ITIM Y2/5/6 has been shown to be binding sites for SHP-1, which has been recognized as the most important down stream effector of CD22 [16] [17] [18] [19] . Therefore, we next investigated CD22 phosphorylation using 10 μg/ml F(ab') 2 anti-chicken IgM to activate BCR and compared the CD22-SHP-1 interaction among the ITIM mutants. As shown in Figure 2E , F1/2/5/6 has almost totally abolished BCR-induced tyrosine phosphorylation and disrupted the CD22/SHP-1 interaction, as compared to CD22-WT. F5/6 also caused a mild decrease in tyrosine phosphorylation signal and a moderate decrease in CD22/ SHP-1 interaction. These results confirmed that ITIM residues Y2/5/6 account for almost complete binding to SHP-1, as suggested by previous studies [18, 19] .
Next we examined the effect of ITIM tyrosine residues on the association between CD22 and PMCA by co-IP assay ( Figure 2F) . ] i caused by the non-ITIM Y3 and Y4? The following experiments were performed to answer this question. As shown in Figure 3A and Table I extrusion, which is a more direct index reflecting PMCA's activity, using same method as in the previous study [39] . In accordance to the changes in Ca 2+ i
in Figure 3B , Figure 3C ), getting close to the Empty vector's level (6.5±1.3% at 300sec; p > 0.05 vs CD22-WT). These results further indicated that between Y3 and Y4, Y3 is dispensable, but Y4 is a key residue responsible for CD22's ITIM-independent negative regulatory function. Furthermore, our results demonstrated that although both ITIMs and non-ITIM were responsible for the negative regulation of Ca 2+ signal, non-ITIM Y4 is more important than ITIM Y2/5/6 and contributed to 69.4~71.7% of the CD22's negative regulation.
Previous studies have shown that Y4 recruits Grb2 when Y4 is phosphorylated [19, 20] . The SH2 domain of Grb2 directly binds to phosphorylated Y4 with an asparagine (N) in the +2 position (N830) to form a Grb2 binding motif of pYXNV. Therefore, the binding could be disrupted not only by mutation of Y4 to F4, but also by mutation of the N830 to aspartate (D; N830D) [40] . To further verify whether Y4 and Y4-associated Grb2 binding motif play a significant role in the negative regulation of Ca signal ( Figure 3E ; Table I ) and Ca 2+ i extrusion (9.68±0.9% at 300sec; p > 0.05 vs CD22-WT; Figure 3F ).
Furthermore, F1/2/5/6+N830D almost totally abolished CD22's inhibitory function ( Figure 3D ; Table I ), similar to F1/2/4/5/6's effect ( Figure 3B ). These results further revealed that Y4 and Y4-associated Grb2 binding motif are necessary for CD22's inhibitory function.
Next we examined 10 μg/ml IgM-activated CD22 phosphorylation and compared the CD22-SHP-1 interaction among the various non-ITIM mutants. As shown in Figure 3G , F3/4, F4, and N830D had no significant effect on IgM-activated CD22 phosphorylation, as compared to CD22-WT. N830D and F4 held a completely intact, while F3/4 had a mild decreased association with SHP-1, as compared with CD22-WT. These results indicated that both F4 and N830D had no significant effects on both tyrosine phosphorylation and SHP-1 recruitment.
We then determined the impacts of Y3 and Y4 and Y4-affiliated Grb2 binding motif on the association between CD22 and PMCA by co-IP assay ( Figure  3H 
Y4, Y4-affiliated Grb2 binding motif, and Grb2 are essential for cD22/PMcA pathway
It has been shown that phosphor-Y4 (pY4) is the binding site for Grb2 after BCR activation [19, 20, [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] . To investigate the role of Grb2 on the CD22/PMCA pathway, we made a Grb2
-/-DT40 cell line by CRISPR/ Cas9 method. We obtained two successful clones, one with single base pair deletion and another with 5 base pair deletions in the target region of the Grb2 gene. In both cases, the deletions resulted in a frame shift and thus truncation of Grb2 protein (Supplementary Figure 1S) .
After comparison of the IgM expression, the clone with 5 base pair deletions was selected for studying the impacts of Grb2 null(Grb2 Table I ) and an indistinguishable difference in Ca 2+ i extrusion. However, compared to Grb2
signal, with a mildly increased Ca 2+ i extrusion (10.3±2.3% vs 13.1±2.5% at 300sec, p > 0.05; Figure 4C ).
As a rescue experiment, we transfected full-length WT chicken Grb2 cDNA back to the Grb2 -/-cells, with (Grb2
signal ( Figure 4B ; Table I ) and mildly increased Ca vector (CD22 -), CD22-WT, and a series of mutant forms, as indicated. Cells with equal levels of membrane IgM and expressed CD22 were stimulated with 1 μg/ml F(ab')2 anti-chicken IgM (arrows) for 2.5 min. In A., b., D., and E., the Ca signal ( Figure 4B ; Table I ) and stimulatory function on Ca 2+ i efflux (24.5±3.1% at 300sec; p < 0.05; Figure 4D ). Next, we asked if CD22/PMCA association is dependent on Grb2? We transfected mouse CD22-WT into Grb2 -/-DT40 cells and found that CD22 and PMCA failed to associate with each other, either with or without BCR activation ( Figure 5A ). We further transfected chicken Grb2 cDNA back to Grb2 -/-DT40 cells, CD22 regained its association with PMCA ( Figure 5A ). These results indicated that the association between CD22 and PMCA required Grb2 as a mediator.
In order to further test whether Grb2 provided a bridge for CD22 and PMCA association and compare the effect of ITIM and non-ITIM tyrosines on this BCR-activation-induced formation of the CD22/Grb2/ PMCA complex, we performed co-IP assays using anti-Grb2 antibodies from lysate of Grb2 -/-or normal DT40 cells which were transfected with CD22-WT or serial CD22 mutants. In Grb2
-/-cell lysate we failed to precipitate Grb2 and co-precipitate both CD22 and PMCA. In normal DT40 cell lysate, results showed that CD22/Grb2/PMCA complex were intact from lysates of CD22-WT and its F1/2/5/6 and F5/6 mutants, but were disrupted in the mutants of F3/4, F4, N830D, F1/2/4/5/6, and F1/2/5/6+N830D ( Figure 5B ). These results further demonstrated that the CD22/Grb2/PMCA complex is formed through BCR activation-induced Y4 phosphorylation and Y4-assocaited Grb2-binding motif to recruit Grb2, which mediates the association of CD22 and PMCA. These results also further excluded the possibility that ITIM and SHP-1 are involved in mediating the interaction.
Is the association between PMCA and Grb2 also BCR activation-dependent? Co-IP approach from normal DT40 cell lysate showed that PMCA consistently associates with Grb2, regardless of the presence or absence of CD22, and regardless of with or without BCR activation ( Figure 5C ).
Above work was performed in the chicken DT40 cells, which is easily accessible to molecular manipulations. However, the physiological relevance may be limited because of its immaturity. We next to ask whether the pathway of CD22/Grb2/PMCA to inhibit Ca 2+ i
signal is also working in human mature B cells?
We first confirmed the expression of the three proteins in Daudi cells, a human Burkitt's lymphoma cell-line (data not shown). We then transfected specific siRNA against CD22 into Daudi cells and successfully inhibited most of the CD22 expression ( Figure 6A) . We compared the Ca 2+ i signal with or without CD22 inhibition. As a result, inhibition of CD22 significantly potentiated the Ca
signal (Δpeak 18.2±3.5%; ΔAUC 3090±148%.s; both p < 0.01), as compared to the cells transfected with scramble oligonucleotides ( Figure 6B ).
To determine whether CD22/Grb2/PMCA can form complexes in normal human B cells, we next isolated peripheral B cells, cultured for a short time, stimulated with 5 μg/ml anti-human F(ab')2 IgM, made cell lysate, and performed immuno-precipitation experiments. We found that the complex of CD22/Grb2/PMCA was associated together only after BCR activation, independent of the sequence of proteins precipitated ( Figure 6C ). However, Grb2 and PMCA, but not CD22, were always bound to each other even without BCR cross-linking. These results were consistent with above observations in DT40 cells and indicated that CD22/Grb2/PMCA complexes can be observed in normal human B cells.
At last, how does PMCA associate with Grb2, directly or indirectly? In order to answer this key question, we expressed human Grb2 in bacteria and fulllength human PMCA4b in HEK293T cells. As shown in Figure 7A , purified GST-Grb2 specifically pulled down PMCA4b. The molecule of the human PMCA4b has four major cytoplasmic fragments and they are NT (AA 1-92 Figure 7B ). We further expressed and purified these four GST-fusion fragmental proteins and full-length 6His-Grb2 in bacteria. In pull-down assay, we found that, only its CT bound with full-length 6His-Grb2 ( Figure 7C ). These results demonstrated that Grb2 interacted directly with PMCA4b.
DIscUssION
The previous study demonstrated that six tyrosines present at CD22 cytoplasmic domain and their phosphorylation are prerequisites for its interaction with PMCA [39] . In this study, by screening the changes in Ca a series of CD22 mutants, we found that pY4 is the key for its association with PMCA. We also found that the interaction between CD22 and PMCA is indirectly mediated by Grb2. Grb2 is constitutively associated with PMCA in both DT40 and human B cells. In vitro pulldown experiments using purified proteins demonstrate a direct interaction between Grb2 and PMCA. Furthermore, we identified the CD22/Grb2/PMCA pathway as a major route for its negative regulation of Ca [32, 34] . Since 1999, several studies have demonstrated that following BCR cross-linking CD22 recruits Grb2 through its pY4 and Grb2's SH2 domain binds directly to CD22's pYENV motif [19, 20, 29] .
However, the physiological significance of Grb2 recruitment to CD22's pY4 has been unclear [32] [33] [34] [35] [36] [37] [38] . In this study we identified for the first time that the significance is to inhibit Ca 2+ i signal by recruiting PMCA. Grb2 directly binds to PMCA C-terminus, which contains neither SH2 domain nor other recognized tyrosine-binding motif [41] , but has a calmodulin binding site and a Ca Figure 7B ) [42] .
The domain(s) mediating the binding of Grb2 to PMCA C-terminus is not addressed in this study. Grb2's N-terminal SH3 domain preferentially binds to proline-rich peptides-containing proteins, such as SOS (a Ras-guanine nucleotide exchange factor) [43] . We thus searched and did not find any remarkable prolinerich regions in the whole sequence of PMCA4b. Grb2's C-terminal SH3 domain binds to peptides conforming to a P-X-I/L/V/-D/N-R-X-X-K-P motif that allows it to specifically bind to proteins such as Gab-1 [8] . In B cells, Grb2's C-terminal SH3 domain has been identified to be critically important for its inhibitory regulation of Ca 2+ signal [32] . Therefore, Grb2 may directly bind to PMCA through its C-terminal SH3 domain. Further study is needed to address this issue.
Next, whether CD22/Grb2/PMCA module associates with effector proteins is still unknown. In B cells, Grb2 at least binds to SOS and Dok-3 (hematopoietic protein downstream of kinase-3), both of which have been reported to be involved in the negative regulation of BCR signaling and contain a typical YXNV domain [32, 34, 43] . SOS may associate with the CD22/Grb2/PMCA module. It is best known that Grb2 constitutively binds with its N-terminal SH3 domains to the proline-rich regions of SOS to form a stable complex to activate Ras [43] . SOS-mediated exchange of GDP for GTP activates Ras, which in turn activates the protein kinase Raf and subsequently the extracelluar signal-regulated kinase (Erk), which is one of the MAPK pathways. Grb2 may be recruited to the membrane by SOS through SH2 domain of Grb2. In this case, CD22 or SOS may compete for the binding to Grb2, since Grb2 has only one SH2 domain. Therefore, the most possible context that depicts SOS's association with the CD22/Grb2/PMCA module is that Grb2's N-terminal SH3 domain binds to proline-rich domain-containing SOS [43] , Grb2's C-terminus SH3 domain binds to PMCA, and Grb2's SH2 domain bind to CD22.
Dok-3 may facilitate the CD22/Grb2/PMCA module formation by recruiting Grb2 to plasma membrane. Dok-3 is an adaptor protein highly expressed in B cells and plays a significant role in the negative regulation of BCR signaling [34] . Dok-3 is permanently tethered at the inner leaflet of the plasma membrane via its pleckstrin homology (PH) domain and Grb2 binds via its SH2 domain to tyrosine phosphorylated Dok-3 following BCR activation [34] . Thus, phosphorylated Dok-3 provides a 'membrane zip code' for Grb2 and the majority of cytosolic Grb2 is recruited to the plasma membrane by this interaction. In DT40 cells that represent an immature B cell stage, Grb2 recruitment is strictly Dok-3-dependent [34] . Dok-3 appears to direct Grb2 into a distinct membrane compartment, where Grb2 forms Dok-3/Grb2 complexes and these complexes inhibits Btk, resulting in decreased PLC-γ2 activity. Recent studies showed mice deficient in Dok-3 exhibit enhanced BCR-induced Ca
response [32, 34, 36, 37] , suggesting that Dok-3/Grb2 complexes also inhibit BCR signaling in mammalian B cells. Honma, et al. also showed that overexpression of Dok-3 could inhibit the recruitment of the Grb2/SOS complex [44] .
Together with either SOS or Dok-3, CD22/Grb2/ PMCA complexes could be generated to enhance PMCA's Ca 2+ i -pumping activity. These associations and activity necessary for increasing PMCA function might be very rapid and transitory. Further studies will be required to address how PMCA get activated after the complexes are formed.
Our results integrate the whole image of the negative regulation of BCR-activation-induced Ca 2+ i signal. Grb2 not only attenuates IP 3 production and subsequent IP 3 -induced Ca 2+ i release (IICR) by forming Dok-3-Grb2 complexes to inhibit PLC-γ2 activity [34] , but also potentiates Ca identified to inhibit Ca 2+ signaling in both mature and immature splenic B cells isolated from the B-cell-specific Grb2-deficient mice [36, 37] , in addition to avian DT40 cells. It is well known that IP 3 production determines the height of the initial Ca 2+ i spike and less IP 3 production causes less IICR, which manifests as a lower initial Ca 2+ i spike and less subsequent SOCE [34, 45] . In the absences of Ca 2+ o and SOCE, the sustained phase of Ca 2+ i signaling is mainly determined by PMCA and Na + -Ca 2+ exchanger (NCX) and thus experiment revealing the precise effect of PMCA on the sustained phase are needed to be performed under the blockade of NCX activity [46] . Grb2-dependent inhibition of IP 3 production and potentiation of PMCA activity could result in an attenuated Ca 2+ i signal, which manifests as a lower initial spike and shortened sustained phase. In this study, transfection of CD22 into Grb2 spike with some effects on the sustained phase ( Figure 4A ), similarly to the previous report in mouse Grb2
-/-cells [37] . Does the constitutively-existed Grb2/PMCA complex bind only to CD22 to execute their Ca signaling. It is possible that other inhibitory receptors like FcγRIIb, Siglec-G, IgG/ IgE could substitute for CD22 to bind and activate Grb2/ PMCA function [1, 2, 11, 24, 35] .
Our data suggest that Grb2/PMCA is a "tunable" regulator of B cell activation and is essential for B cell development and function. Furthermore, given the ubiquitous expression of Grb2 [31, 32, 34, 36, 37] and the widespread existence of PMCA [47] in both avian and mammalian cells, it is conceivable that the interaction of the Grb2/PMCA complex with other tissue-specific negative regulators may provide a general mechanism for regulating intracellular Ca 2+ i signaling.
MAtErIALs AND MEtHODs cell culture
The chicken B cell line DT40 (CRL-2111) and the Burkitt's lymphoma cell line Daudi were purchased from ATCC. DT40 cells were cultured in RPMI 1640 medium (Life Technologies) supplemented with 10% heat-inactivated fetal bovine serum, 1% heat-inactivated chicken serum, 2mM L-glutamine, 1 mM sodium pyruvate and nonessential amino acids, 1 mM nonessential amino acids (GIBCO Life Technologies), 50 microM 2-mercaptoethanol, 100 U/ml penicillin, and 100 μg/ ml streptomycin. The cells were maintained below a density of 3x10 6 cells/ml. Daudi cells were maintained by serial passages in RPMI 1640 medium containing 10% heat-inactivated fetal bovine serum and 100 mM L-glutamine. HEK-293T cells were cultured and passaged in Dulbecco's modified Eagle's medium (DMEM; GibcoLife) supplemented with 4500mg/L high glucose and 10% fetal bovine serum.
Isolation of normal human peripheral b cells
Healthy blood donors (4 men, 3 women) ranged in age from 42 to 57 years. This study was approved by the Institutional Review Board. Written consent was obtained in each case. Peripheral-blood mononuclear cells were isolated from EGTA-treated venous blood samples by density gradient centrifugation using Ficoll-Paque (Amersham-Pharmacia Biotech, Piscataway, NJ). B cells were isolated from mononuclear cells by CD19 or CD20 selection using immunomagnetic MACS micro-beads (Miltenyi Biotech, Auburn, CA). After isolation, the cells were cultured for a few hours and stimulated with goat anti-human F(ab')2 IgM (Thermo).
Molecular cloning and mutagenesis
To construct chicken expression vector (pApuro) harboring the chicken β-actin promoter and puromycinresistant gene, we used pBabe-puro vector (Addgene) as a backbone [48] . The vector contains three PstI sites that were used to digest the vector into three fragments. An 872bp fragment between the first and the second PstI site containing the Moloney murine leukemia virus long terminal repeat (LTR) was deleted from the vector and a 176bp fragment between the second and the third PstI site containing the truncated gag was recovered from agarose gel, purified, and re-connected back to the vector. The correct ligation direction was verified by sequencing. A 1283bp fragment containing a chicken β-actin promoter was amplified by PCR using a high-fidelity polymerase KOD-FX-neo (Toyobo, Japan) from chicken genomic DNA [49, 50] . The primers used were β-actin-F: 5'-GGATCCGTGAGCCCCACGTTCTGCTTC-3' and β-actin-R: 5'-GGATCCGGCTGGCTGCGGAGGAACAGA-3'. Then the PCR fragment was inserted into a unique BamHI site of the above modified pBabe-puro, resulting pApuro vector [51] .
One microgram of total RNA, isolated from either mouse splenic B cells, or DT40 cells, or normal human B cells using TRIzol (Invitrogen), was reversely transcribed into cDNA using Biovisualab RTkit (Shanghai, China). The full-length mouse CD22 cDNA was amplified by PCR using KOD-FX-neo with www.impactjournals.com/oncotarget primers: mCD22-F primer (5' -CCCAGTGTGGTGGTA CGTAGGAATTCATGCGCGTCCATTACCTGTGGC -3') and mCD22-R primer(5'-ACTGACACACATTCCA CAGGGTCGACTCAGTGCTTGAGGGTCACATAGT -3'). The PCR product was cloned into the pApuro between EcoRI-SalI sites using GBI-clonart seamless ligation kit (Genbank Bioscience, Suzhou, China). Obtained pApuro-CD22 constructs were sequenced and matched with Genbank sequences (CD22: NM_001043317.2).
The CD22 mutants with cytoplasmic tyrosines changing to phenylalanine were made in multiple steps. First, we abolished the cDNA 1541~1546 ApaI site (GGGCCC) by mutating 1545C→A. Then, we created a novel 2296~2301 ApaI site by mutating 2298C→G. Afterwards, we amplified a 320bp fragment from a CD22 cytoplasmic far C-terminus by overlap extension PCR using various mutagenic primers. The forward primers contain the 5'-Apa I site and the reverse primers contain the 5'-SalI site. The PCR products with mutations of tyrosine to phenylalanine, or asparagine to aspartic acid, or both, were cloned back into pApuro-CD22 construct with ApaI-SalI double cuts. The resultant mutants were selected by sequencing ( Figure 1B) .
The full-length chicken Grb2 cDNA were obtained by PCR using cGrb2-F primer(5'-CCCAGTG TGGTGGTACGTAGGAATTCATGGAAGCCATCGC CAAATAC -3') and cGrb2-R primer (5' -ACTGACA CACAGGGTCGACCTAGATGTTCCGGTTCACTG -3'). The PCR product was cloned into the pApuro vector between EcoRI-SalI sites. The full-length human Grb2 cDNA was obtained by PCR using the hGrb2-F primer (5'-TGGTTCCGCGTGGAT CCCCGGAATTCATGGAAGCCATCGCCAAATATG -3') and hGrb2-R primer (5' -GATCGTCAGTCAGTCAC GATGCGGCCGCTTAGACGTTCCGGTTCACGG -3') and was cloned into the pGEX-4T-1 between EcoRI-NotI sites and the pET-28A(+) between BamHI-XhoI sites. The full-length human PMCA4b (3618bp) cDNA were obtained by PCR using the hPMCA4b-F primer (5' -AGCTGGCTAGTTAAG CTTGGTACCAAAATGACGAACCCATCAGACCG -3') and hPMCA4b-R primer (5' -TTTTTGTTCGAAGG GCCCTCTAGAAACTGATGTCTCTAGGCTCTG -3') and was cloned into the pcDNA3.1-myc/his(+) between KpnI-XbaI sites. The N-terminus (NT; AA 1-92), the first (Loop-1; AA 172-356) and second (Loop-2; AA 428-840) cytoplasmic loops, and the C-terminus (CT; AA 1048-1241) of the human PMCA4b, were amplified by PCR from the full length cDNA and ligated into pGEX-4T-1 between EcoRI-NotI sites. All constructs were fully sequenced in both directions and matched with Genbank sequences (chicken Grb2: EF062570.1; human Grb2: NM_002086.4; human PMCA4b: NM_001684.4).
Plasmid and sirNA transfection
DT40 cells were transfected with mouse CD22-WT, CD22 mutants, or chicken Grb2 a Gene Pulser II electroporation system and the Capacitance Extender Plus module (Bio-Rad) according to the manufacturer's instructions. Stable transfectants were selected in 0.5 μg/ ml puromycin and puromycin-resistant clones with similar expression of CD22 and surface IgM, as measured by flow cytometry, were used for study. siRNA for human CD22 were synthesized by RiboBio (Guangzhou, China) (CD22-1: 5'-GGAAGUUCCUCUCCAAUGAdTdT-3', CD22-2: 5'-CAUGCCGAUUCGAGAAGGAdTdT-3'). Daudi cells cells were transfected with siRNA for 72~96 hours. HEK-293T cells were transfected with plasmid for 48 hours [52, 53] .
GST-and 6His-fusion protein expression, purification and pull-down assay
All GST-and 6His-fusion proteins were expressed in BL-21 cells by induction of isopropyl-Dthiogalactopyranoside and purified through glutathionesepharose beads (Sigma G4510) or Ni-beads (Qiagen, Cat-70666), as described previously [54] . 6His-fusion proteins were eluted from Ni-beads with 250mM imidazole and followed by a dialysis. HEK293 cells over-expressed with PMCA4b were lysed in TLB buffer (20 mM Tris-HCl, 137 mM NaCl, 2 mM EDTA, 10% glycerol, 1% Triton X-100, 25 mM β-glycerol phosphate, 0.01μg/ml each of aprotinin, leupeptin and pepstatin A, 2mM phenylmethylsulfonyl fluoride, pH 7.4) and microfuged. The supernatant, or purified 6His-fusion proteins, was mixed with GST or GST-fusion proteins in TLB buffer, rocked for 2 hour at 4 o C. The beads were then washed three times with TLB buffer, and boiled in SDS sample buffer. The bound proteins were resolved by SDS-PAGE and immunoblotted with the indicated antibodies.
Antibodies
The Anti-mouse CD22 antibody were purchased from BD (BD Biosciences Pharmingen) [39] . The polyclonal antibodies against Grb2 were purchased from Santa Cruz (C-23) and monoclonal antibodies against Grb2 were from BD. The anti-PMCA mouse monoclonal antibodies 5F10 and JA3 were obtained from Abcam (ab2825) and Santa Cruz (SC-20027) respectively.
Measurement of [ca

2+ ] i
Cells (2 x 10 6 ) were incubated with 2 μM Fura-2AM (Molecular Probes) for 30 min at 37 o C in Fura-2 buffer [135mM NaCl, 1mM CaCl 2, 1mM MgCl 2 , 5mM KCl, 10mM glucose, 10mM HEPES, and 0.1%BSA (Sigma), pH 7.4]. Fura-2 buffer was also used as extracellular medium for measuring [Ca 2+ ] i . The Ca 2+ -free buffer consisted of Fura-2 buffer with CaCl 2 replaced by 1mM EGTA. Fluorescence from cells in suspension was monitored with a QuantaMaster Series fluorometer (PTI, USA) at excitation wavelengths of 340 nm and 380 nm and an emission wavelength of 510 nm. Anti-chicken IgM M4 or anti-human IgM (1~10 μg/ml) was used to activate BCR on B cells [14] . Because the fura-2 method has several intrinsic problems in the estimation of absolute [Ca 2+ ] i [55] ] o elevation in response to BCR activation was calculated using the percentage of increase of F340/F380 with reference to F340/F380 at the resting state. The percentage at 300 seconds after BCR stimulation was set as a point for comparison between groups.
Immunoprecipitation and immunoblotting
Cells were solubilized in 1% NP-40 lysis buffer (137mM NaCl, 10% glycerol, 1% NP-40, 20mM TrisHCl, pH 7.5) with a proteinase inhibitor mixture (1 μg/ml aprotinin, 1 μg/ml leupeptin, 1 μg/ml pepstatin A, 1 mM phenylmethylsulfonyl fluoride; all from Sigma). Lysates were incubated sequentially with appropriate antibodies and protein A/G-agarose (Roche). The immunoprecipitants were washed four times with lysis buffer, boiled in SDS-sample buffer, and resolved by electrophoresis in a 7~12% SDS-PAGE, followed by blotting onto polyvinylidene difluoride membranes (Millipore). After overnight incubation at 4°C with primary antibodies (1:1000, otherwise noted), blots were washed 4 times in PBS containing 0.05% Tween-20 and then incubated with HRP-conjugated secondary antibodies (1:1000 dilution) for 1 hour at room temperature before extensive washes. The blots were visualized using an ECL detection kit (Thermo-Pierce) on the Chemi Doc TM XRS + (Bio-Rad).
Knockout of chicken Grb2 gene by CRISPR/ cas9-grNA
The Grb2-specific guide RNA (gRNA) sequence preceding the PAM motif for CRISPR/Cas9 interference were designed from the region of the exon-1 of the chicken Grb2 gene ( Figure 1S ) and were tested to avoid obvious potential off-target effects by bioinformatics analysis (http://www.e-crisp.org) [53, 57] . The pVK-001-08 plasmid with avian promoter cU6 was purchased from Weishanglide (Beijing, China; Figure 1S ). The gRNA sequence was obtained by annealing two primers (Target-F: AAACACCG-GACGAGCTGAGCTTCAAA; Target-R: CTCTAAAAC-TTTGAAGCTCAGCTCGTC) in the buffer: 40 mMTris-HCl, 20 mM MgCl2, 50 mM NaCl, pH 8.0. The annealed oligonucleotides were inserted into the pre-cut pVK-001-08 and was transformated into E. coli (XL-10-gold). The correct pVK-Grb2 construct was selected by sequencing.
DT40 cells at a density of 2x10 5 cells/ml in a 6-well plate were transfected with 2.5 μg of plasmid pVK-Grb2 by electroporation. Twelve hours post-transfection, media was refreshed. At 72 hours, the cells were re-seeded into a 10 cm dish with 1 μg/mL puromycin. The media with antibiotics was changed every 2 days. Upon complete cell death in the controls (untransfected cells with single puromycin selection) after a week of selection, cells were plated in two 96-well plates at a density of 0.3 cells per well to isolate single cell derived clones. Wells were monitored for single clone expansion. Upon observation, the expanded clone was divided into two parts, half for freezing and half for genomic DNA extraction.
Genomic DNA from transfected and control DT40 cells was extracted using a genome isolation kit (Promega). The genomic fragment was obtained by PCR using KOD-FX-neo and primers (Grb2-Exon1-F: 5'-ACTTCCCCTAATGGCACGGC-3' and Grb2-Exon1-R:
5'-CCAACATTTGACAGCCTGATG-3') under the following conditions: 94 o C for 2min; 35 cycles (94 o C for 40s, 57
o C for 30s, 68 o C for 45s). The fragments from both transfected and control cells were purified, mixed in equal amount, and subjected to reannealing reaction. Re-annealed PCR products were incubated for 30 min at 37 °C in the presence of 10 U of mismatch-sensitive T7 endonuclease I (New England Biolabs) and analyzed by agarose gel electrophoresis. Monoallelic deletion clones were defined as having both the non-deletion band and deletion band. Biallelic deletion clones were defined as having the deletion band and absence of the non-deletion band. Having the non-www.impactjournals.com/oncotarget deletion band and absence of the deletion band were defined as non-deletion clones ( Figure 1S ). By using this assay, two clones with biallelic deletion were selected. They were further expanded and the genomic DNA was extracted. The genomic fragments obtained by PCR once again were purified and directly sequenced with primer 5'-TGTGGAAGGGAATTCAGCAC-3'. They were also checked for the effect of Grb2 knockout by Western blotting.
statistical analysis
All data are given as the mean±S.E. Data were analyzed by using a paired or unpaired Student's t test. P < 0.05 was taken as a significant difference between data sets. ; Cas9, CRISPR associated 9; Co-IP, co-immunoprecipitation; CRISPR, clustered regularly interspaced short palindromic repeats; FcγRII, low-affinity Fc receptor for IgG; Grb2, growth factor receptor-bound protein 2; IB, immunoblot; IP 3 , inositol-1,4,5-trisphosphate; IP, immunoprecipitation; ITIM, immunoreceptor tyrosine-based inhibition motif; Lyn, lck/yes-related protein tyrosine kinase; PLC-γ2, phospholipase C-γ2; PMCA, plasma membrane calciumATPase; SH2, Src homology 2 domain; SHIP, Src homology 2 (SH2)-containing inositol 5'-phosphatase; SHP-1, Src homology 2 domain-containing tyrosine phosphatase-1; SOCE, Store-operated Ca 2+ entry; SOS, Son of sevenless; WT, wild type; Y, tyrosine; pY, phosphotyrosine.
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